Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Financing Cash Flow

$44.15M

TTM · Period ending: · USD

ARMP logo

ARMP Financing Cash Flow

Latest reported$44.15M
ARMP TTM Cash from Financing ($12.70M → $44.15M)
High-resolution chart · PNG

ARMP financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Armata Pharmaceuticals, Inc. Common Stock Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
44,148,000
16,267,000
25,612,000
24,954,000
9,925,000
10,013,000
34,958,000
34,915,000
59,781,000
59,325,000
53,988,000
53,531,000
28,757,000
28,979,000
44,016,000
51,554,000
51,609,000
51,570,000
25,518,000
18,912,000
18,886,000
19,377,000
23,210,000
22,778,000
22,718,000
31,382,000
8,975,000
8,975,000
8,975,000
5,000
0
-206,000
-817,000
8,876,000
8,671,000
12,115,000
12,709,000
7,004,000
7,209,000
3,971,000
3,987,000
396,000
12,780,000
12,780,000
12,781,000
12,384,000
0
18,028,000
18,028,000
26,026,000
27,002,000
8,974,000
8,974,000
976,000
0
-258,000
-258,000
-259,000
-427,000
-1,346,000
16,561,000
24,632,000
23,849,000
25,032,000
7,074,000
3,752,000
4,670,000
2,098,000
1,976,000
-2,971,000
3,099,000
5,273,000
5,215,000
28,970,000
22,723,000
27,757,000
43,839,000
19,997,000
20,624,000
20,597,000
10,007,000
10,005,000
14,514,278
18,093,649
15,013,436
17,315,000
15,726,516
12,746,670
10,321,049
37,356,225
35,018,431
36,103,906
36,648,740
7,800,000
7,600,000
1,000,000
13,400,000
12,900,000
11,900,000
11,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.